3042B |
Metolazone, Blood |
3042SP |
Metolazone, Serum/Plasma |
3043B |
Metoprolol, Blood |
3043FL |
Metoprolol, Fluid |
3043SP |
Metoprolol, Serum/Plasma |
3043U |
Metoprolol, Urine |
3057B |
Midazolam, Blood |
3057FL |
Midazolam, Fluid |
3057SP |
Midazolam, Serum/Plasma |
3057U |
Midazolam as Metabolite, Urine |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3078U |
Mitragynine (Qualitative), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3103B |
Nadolol, Blood |
3103SP |
Nadolol, Serum/Plasma |
3103U |
Nadolol, Urine |
3158B |
Nifedipine, Blood |
3158SP |
Nifedipine, Serum/Plasma |
3168B |
Nitazenes Panel, Blood |
3175B |
Nitrazepam and Metabolite, Blood |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
3175U |
Nitrazepam and Metabolite, Urine |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3410B |
Pentobarbital, Blood |
3410SP |
Pentobarbital, Serum/Plasma |
3410U |
Pentobarbital, Urine |
3788B |
Prazosin, Blood |
3788SP |
Prazosin, Serum/Plasma |